Evidence map›Paper›PMID 36524736›Full record

ArticleHead & neck2023

No survival benefit in never-smoker never-drinker patients with oral cavity cancer.

Emily Z Yan, Benjamin M Wahle, Erik R Nakken, Smrithi Chidambaram, Kayla Getz, Wade L Thorstad, Jose P Zevallos, Angela L Mazul

Open access · greenAbstract read
In one paragraph

Article in Head & neck, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Emily Z YanDepartment of Otolaryngology-Head and Neck Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.ORCID 0000-0002-9619-1256
Benjamin M WahleDepartment of Otolaryngology-Head and Neck Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.
Erik R NakkenDepartment of Otolaryngology-Head and Neck Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.
Smrithi ChidambaramDepartment of Otolaryngology-Head and Neck Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.ORCID 0000-0001-5650-8821
Kayla GetzDivision of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.
Wade L ThorstadDepartment of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri, USA.ORCID 0000-0002-2757-0543
Jose P ZevallosDepartment of Otolaryngology-Head and Neck Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.ORCID 0000-0002-9111-6767
Angela L MazulDepartment of Otolaryngology-Head and Neck Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.
Washington University in St. Louis · US

Funding

Washington University Institute of Clinical and Translational Sciences (TL1)TL1TR002344 · NCATS · WASHINGTON UNIVERSITY · PI Jay F. Piccirillo · 2017 to 2026
$8.5M
DEVELOPMENT OF CLINICIAN/RESEARCHERS IN ACADEMIC ENTT32DC000022 · NIDCD · WASHINGTON UNIVERSITY · PI PICCIRILLO, JAY F. · 1989 to 2022
$5.6M
Postdoctoral Training in Cancer Prevention and ControlT32CA190194 · NCI · WASHINGTON UNIVERSITY · PI GRAHAM A. COLDITZ, AIMEE S JAMES · 2014 to 2026
$4.7M
SHORT-TERM TRAINING STUDENTS IN HEALTH PROFESSIONAL SCHOT35HL007815 · NHLBI · WASHINGTON UNIVERSITY · PI CHUNG, KOONG-NAH · 1995 to 2020
$2.8M
Development of a Four-Class, Molecular Subtyping Diagnostic for HPV-negative Head and Neck CancerR01CA211939 · NCI · WASHINGTON UNIVERSITY · PI HAYES, DAVID N, ZEVALLOS, JOSE P. · 2017 to 2021
$2.3M
Integrating social and molecular determinants of HPV-associated cancersK01MD013897 · NIMHD · WASHINGTON UNIVERSITY · PI MAZUL, ANGELA LIU · 2020 to 2023
$519k
NCATS NIH HHS TL1 TR002344NCI NIH HHS R01 CA211939NCI NIH HHS T32 CA190194NHLBI NIH HHS T35 HL007815NIDCD NIH HHS T32 DC000022NIMHD NIH HHS K01 MD013897
6 · The paper itself

Abstract

backgroundAlthough strongly associated with tobacco and alcohol use, many oral cavity squamous cell carcinoma (OCSCC) cases occur in patients without exposure to either, known as "never-smoker, never-drinkers" (NSND). We aimed to compare clinical outcomes between NSND and tobacco/alcohol-exposed populations and to define demographic characteristics of NSND.

methodsWe performed a retrospective, single-institution cohort study of 672 OCSCC patients. Cox models were used to estimate differences in overall survival (OS) and recurrence-free survival (RFS) between NSND and tobacco/alcohol-exposed patients while adjusting for confounders.

resultsNSND represented 25.6% of our cohort and were older, more female, and more economically advantaged. Among NSND, oral tongue tumors dominated in younger patients, while alveolar ridge tumors dominated in elderly patients. Multivariate survival analysis revealed no differences in OS or RFS between NSND and tobacco/alcohol-exposed patients.

conclusionWhen adjusted for independent biologic features, clinical outcomes in OCSCC are similar between NSND and tobacco/alcohol-exposed patients.

Indexed as

Carcinoma, Squamous CellHead and Neck NeoplasmsMouth NeoplasmsAgedCohort StudiesFemaleHumansRetrospective StudiesSmokersSmokingSquamous Cell Carcinoma of Head and Neckalcoholhead and neck squamous cell carcinomanever-smoker never-drinkeroral cavity squamous cell carcinomasurvivaltobacco

Identifiers

PMID36524736
PMCPMC9898183
OpenAlexW4311665509

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.